RNA tailing machinery drives amyloidogenic phase transition.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
04 Jun 2024
Historique:
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 28 5 2024
Statut: ppublish

Résumé

The RNA tailing machinery adds nucleotides to the 3'-end of RNA molecules that are implicated in various biochemical functions, including protein synthesis and RNA stability. Here, we report a role for the RNA tailing machinery as enzymatic modifiers of intracellular amyloidogenesis. A targeted RNA interference screen identified Terminal Nucleotidyl-transferase 4b (TENT4b/Papd5) as an essential participant in the amyloidogenic phase transition of nucleoli into solid-like Amyloid bodies. Full-length-and-mRNA sequencing uncovered starRNA, a class of unusually long untemplated RNA molecules synthesized by TENT4b. StarRNA consists of short rRNA fragments linked to long, linear mixed tails that operate as polyanionic stimulators of amyloidogenesis in cells and in vitro. Ribosomal intergenic spacer noncoding RNA (rIGSRNA) recruit TENT4b in intranucleolar foci to coordinate starRNA synthesis driving their amyloidogenic phase transition. The exoribonuclease RNA Exosome degrades starRNA and functions as a general suppressor of cellular amyloidogenesis. We propose that amyloidogenic phase transition is under tight enzymatic control by the RNA tailing and exosome axis.

Identifiants

pubmed: 38805292
doi: 10.1073/pnas.2316734121
doi:

Substances chimiques

Amyloid 0
RNA 63231-63-0
Polyribonucleotide Nucleotidyltransferase EC 2.7.7.8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2316734121

Subventions

Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R35GM149221
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R01GM115342
Organisme : HHS | NIH | National Cancer Institute (NCI)
ID : R01CA275828
Organisme : HHS | NIH | National Institute on Aging (NIA)
ID : K99AG080474
Organisme : HHS | NIH | National Cancer Institute (NCI)
ID : F30CA243268
Organisme : HHS | NIH | National Institute of Mental Health (NIMH)
ID : R01MH104656
Organisme : Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)
ID : RGPIN-2018-06209
Organisme : Sylvester Comprehensive Cancer Center, University of Miami Health Systems (Sylvester Comprehensive Cancer Center)
ID : PG006169

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Michael Bokros (M)

Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, Cancer Epigenetics Program, University of Miami, Miami, FL 33136.

Nathan C Balukoff (NC)

Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, Cancer Epigenetics Program, University of Miami, Miami, FL 33136.

Alex Grunfeld (A)

Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, Cancer Epigenetics Program, University of Miami, Miami, FL 33136.

Mathew Sebastiao (M)

Department of Chemistry, Université du Québec à Montréal, Montreal QC H3C 3P8, Canada.
Quebec Network for Research on Protein Function, Engineering, and Applications, PROTEO, Montreal, QC H3C 3P8, Canada.

Eléonore Beurel (E)

Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136.
Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136.

Steve Bourgault (S)

Department of Chemistry, Université du Québec à Montréal, Montreal QC H3C 3P8, Canada.
Quebec Network for Research on Protein Function, Engineering, and Applications, PROTEO, Montreal, QC H3C 3P8, Canada.

Stephen Lee (S)

Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, Cancer Epigenetics Program, University of Miami, Miami, FL 33136.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH